"Ustekinumab/pharmacokinetics"[MAJR] - Search Results

Year	Number of Results
2015	1
2016	2
2017	3
2018	1
2020	2
2021	2
2022	1
2023	1
2024	3

1

Ustekinumab pharmacokinetics after subcutaneous administration in swine model.

Grabowski T, Burmańczuk A, Derlacz R, Stefaniak T, Rząsa A, Borkowski J. Grabowski T, et al. J Vet Sci. 2021 Sep;22(5):e47. doi: 10.4142/jvs.2021.22.e47. Epub 2021 May 27. J Vet Sci. 2021. PMID: 34423596 Free PMC article.

2

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.

Adedokun OJ, Xu Z, Gasink C, Jacobstein D, Szapary P, Johanns J, Gao LL, Davis HM, Hanauer SB, Feagan BG, Ghosh S, Sandborn WJ. Adedokun OJ, et al. Gastroenterology. 2018 May;154(6):1660-1671. doi: 10.1053/j.gastro.2018.01.043. Epub 2018 Feb 1. Gastroenterology. 2018. PMID: 29409871 Free article.

3

Ustekinumab and Vedolizumab Exposure Is Unaffected by Pharmacogenetic Determinants of Anti-TNFs Pharmacokinetics.

Alsoud D, Verstockt B, Vermeire S. Alsoud D, et al. Inflamm Bowel Dis. 2024 May 2;30(5):874-875. doi: 10.1093/ibd/izae035. Inflamm Bowel Dis. 2024. PMID: 38581670 No abstract available.

4

Population Pharmacokinetics and Exposure-Response Modeling Analyses of Ustekinumab in Adults With Moderately to Severely Active Ulcerative Colitis.

Xu Y, Hu C, Chen Y, Miao X, Adedokun OJ, Xu Z, Sharma A, Zhou H. Xu Y, et al. J Clin Pharmacol. 2020 Jul;60(7):889-902. doi: 10.1002/jcph.1582. Epub 2020 Feb 5. J Clin Pharmacol. 2020. PMID: 32026499

5

Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study.

Rosh JR, Turner D, Griffiths A, Cohen SA, Jacobstein D, Adedokun OJ, Padgett L, Terry NA, O'Brien C, Hyams JS. Rosh JR, et al. J Crohns Colitis. 2021 Nov 8;15(11):1931-1942. doi: 10.1093/ecco-jcc/jjab089. J Crohns Colitis. 2021. PMID: 34037715 Free PMC article. Clinical Trial.

6

Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease.

Vasudevan A, Tharayil V, Raffals LH, Bruining DH, Becker M, Murad MH, Loftus EV Jr. Vasudevan A, et al. Inflamm Bowel Dis. 2024 Apr 3;30(4):660-670. doi: 10.1093/ibd/izad065. Inflamm Bowel Dis. 2024. PMID: 37071852 Free PMC article.

7

Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Pan S, Tsakok T, Dand N, Lonsdale DO, Loeff FC, Bloem K, de Vries A, Baudry D, Duckworth M, Mahil S, Pushpa-Rajah A, Russell A, Alsharqi A, Becher G, Murphy R, Wahie S, Wright A, Griffiths CEM, Reynolds NJ, Barker J, Warren RB, David Burden A, Rispens T, Standing JF, Smith CH; BADBIR Study Group, the BSTOP Study Group, the PSORT Consortium. Pan S, et al. Clin Transl Sci. 2020 Mar;13(2):400-409. doi: 10.1111/cts.12725. Epub 2020 Jan 29. Clin Transl Sci. 2020. PMID: 31995663 Free PMC article.

8

Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of Ustekinumab in pediatric patients with inflammatory bowel disease.

Cai X, Wu W, Guo G, Chen J, Xu J, Lin W, Huang P, Lin C, Lin R. Cai X, et al. Eur J Pharm Sci. 2024 Aug 1;199:106807. doi: 10.1016/j.ejps.2024.106807. Epub 2024 May 24. Eur J Pharm Sci. 2024. PMID: 38797440 Free article.

9

Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease.

Battat R, Kopylov U, Bessissow T, Bitton A, Cohen A, Jain A, Martel M, Seidman E, Afif W. Battat R, et al. Clin Gastroenterol Hepatol. 2017 Sep;15(9):1427-1434.e2. doi: 10.1016/j.cgh.2017.03.032. Epub 2017 Mar 29. Clin Gastroenterol Hepatol. 2017. PMID: 28365485

10

Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial.

Wu M, Li X, Yang D, Wang M, Zhang H, Li C, Mai J, Yang L, Qi Y, Yu JC, Yang X, Wang Z, Gu C, Ding Y. Wu M, et al. BioDrugs. 2023 Jan;37(1):89-98. doi: 10.1007/s40259-022-00563-5. Epub 2022 Nov 22. BioDrugs. 2023. PMID: 36417156 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year